Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Medicine|September 3, 2025
Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic responseJin-Shu Pang, Yu Yang, Li Liang, et al.
Abdominal Radiology (New York)|February 5, 2025
Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinomaLi Liang, Jin-Shu Pang, Rui-Zhi Gao, et al.
Oncology Reports|May 7, 2019
Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistryMei Wu, Qi Sun, Chao-Hua Mo, et al.
International Journal of General Medicine|December 15, 2021
Down-Regulation of Activating Transcription Factor 3 (ATF3) in Hepatoblastoma and Its Relationship with FerroptosisJing-Xiao Li, Jin-Shu Pang, Bin-Tong Yin, et al.
British Journal of Clinical Pharmacology|May 24, 2012
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestatGary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Clinical Therapeutics|March 3, 2012
Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markersGary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Chemical Research in Toxicology|July 7, 2011
Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysisAngela K Goodenough, Joelle M Onorato, Zheng Ouyang, et al.
Journal for Immunotherapy of Cancer|July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915Georgina V Long, Hao Tang, Keyur Desai, et al.
BMC Medical Imaging|January 3, 2025
Preoperative prediction of lymph node metastasis in intrahepatic cholangiocarcinoma: an integrative approach combining ultrasound-based radiomics and inflammation-related markersYu-Ting Peng, Jin-Shu Pang, Peng Lin, et al.
Bioengineered|July 26, 2021
Incomplete thermal ablation-induced up-regulation of transcription factor nuclear receptor subfamily 2, group F, member 6 (NR2F6) contributes to the rapid progression of residual liver tumor in hepatoblastomaJin-Shu Pang, Dong-Yue Wen, Rong-Quan He, et al.
Pageof 8